Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $4,213 - $4,755
22 New
22 $4.67 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $540 - $644
4 Added 22.22%
22 $3,000
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $2,963 - $3,814
18 New
18 $3,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Thomas J. Herzfeld Advisors, Inc. Portfolio

Follow Thomas J. Herzfeld Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.